Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TScan Therapeutics, Inc. | 100,000 | reported | 02 Feb 2023 | tx 8+559,670−48,670 |
| SEPRACOR INC /DE/ | 93,626 | reported | 10 Sept 2007 | tx 284+864,550−1,147,823 |
| ROCKET PHARMACEUTICALS, INC. | 31,660 | reported | 18 Jun 2025 | tx 29+1,651,274−514,589 |
| THL Credit, Inc. | 28,300 | reported | 06 Dec 2010 | tx 21+38,500−201 |
| PTC THERAPEUTICS, INC. | 20,850 | reported | 02 Jan 2026 | tx 52+238,775−170,888 |
| Spero Therapeutics, Inc. | 6,073 | reported | 05 Jun 2018 | tx 2+18,219 |
| BIOSPHERE MEDICAL INC | 0 | reported | 10 Sept 2010 | tx 14+32,000−37,055 |
| HUMAN GENOME SCIENCES INC | 0 | reported | 30 Jul 2012 | tx 14+634,835−216,488 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | PTC THERAPEUTICS, INC. | 4,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | PTC THERAPEUTICS, INC. | 3,475 | 0.00 USD | deriv |
| 09 Sept 2025 | SALE | PTC THERAPEUTICS, INC. | 12,000 | 58.34 USD | |
| 09 Sept 2025 | EXERCISE | PTC THERAPEUTICS, INC. | 12,000 | 30.86 USD | |
| 09 Sept 2025 | EXERCISE | PTC THERAPEUTICS, INC. | 12,000 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 30,000 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | PTC THERAPEUTICS, INC. | 4,000 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | PTC THERAPEUTICS, INC. | 8,800 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 23,944 | 0.00 USD | deriv |
| 02 May 2024 | GIFT | ROCKET PHARMACEUTICALS, INC. | 113,124 | 0.00 USD | |
| 02 May 2024 | GIFT | ROCKET PHARMACEUTICALS, INC. | 59,716 | 0.00 USD | |
| 08 May 2024 | GIFT | PTC THERAPEUTICS, INC. | 1,650 | 0.00 USD | |
| 12 Apr 2024 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 70,000 | 4.34 USD | |
| 12 Apr 2024 | SALE | ROCKET PHARMACEUTICALS, INC. | 59,716 | 24.22 USD | |
| 15 Apr 2024 | SALE | ROCKET PHARMACEUTICALS, INC. | 10,000 | 24.05 USD | |
| 15 Apr 2024 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 29,624 | 4.34 USD | |
| 12 Apr 2024 | SALE | ROCKET PHARMACEUTICALS, INC. | 10,284 | 25.16 USD | |
| 12 Apr 2024 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 70,000 | 4.34 USD | deriv |
| 15 Apr 2024 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 29,624 | 4.34 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | PTC THERAPEUTICS, INC. | 4,000 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | PTC THERAPEUTICS, INC. | 10,000 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 25,850 | 0.00 USD | deriv |
| 17 Apr 2023 | SALE | PTC THERAPEUTICS, INC. | 6,241 | 50.69 USD | |
| 17 Apr 2023 | EXERCISE | PTC THERAPEUTICS, INC. | 11,429 | 18.01 USD | |
| 17 Apr 2023 | SALE | PTC THERAPEUTICS, INC. | 5,188 | 51.43 USD |
3 purchases reported after at least 12 months of silence — most recent on 08 Sept 2021.